Expectations trend
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsNASDAQInformation TechnologyHardware, Equipment & PartsSnapshot 2026-10-23
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
A matching fiscal period and sufficient coverage are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Positive cash flow from operations | Syntec Optics improved cash flow from operations from -$3,894 in 2025-Q4 to $469,611 in 2026-Q1. | Improving | cash flow from operations falls below zero | Cash from operations: $-107,355 FY2026-Q2; GAAP. Published target: cash flow from operations > $0. Target period is not explicitly aligned with this observation. Source published Aug 10, 2026-107,355 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextThis priority was stated in prior periods but is not explicitly mentioned in the current disclosures. Cash from operations improved from negative $158,049 in 2025-Q2 to positive $469,611 in 2026-Q1, but no direct current statements confirm ongoing emphasis. Delivery assessment Oct 24, 2026 |
Improvement in operating income | A primary condition in SYNTEC OPTICS HOLDINGS INC's published investment case. The stated target is operating income >= $0. | Broken | operating income remains negative | Operating income: $321,388 FY2026-Q2; GAAP. Published target: operating income >= $0. Target period is not explicitly aligned with this observation. Source published Aug 10, 2026321,388 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 93a79cb1-7e11-42c4-b4a4-7976fe49a393. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextThis priority was stated in prior periods but is not explicitly mentioned in the current disclosures. Operating income improved from a loss of $776,047 in 2026-Q1 to a positive $321,388 in 2026-Q2, indicating progress, but no direct current statements confirm ongoing emphasis. Delivery assessment Oct 24, 2026 |
Revenue growth through strategic partnerships | The company aims to increase revenue through partnerships despite a recent dip to $6.5M in 2026-Q1. | Broken | quarterly revenue falls below $6.5M | Revenue: $8.274M FY2026-Q2; GAAP. Published target: >= $7.5M quarterly revenue. Target period is not explicitly aligned with this observation. Source published Aug 10, 20268,273,858 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 93a79cb1-7e11-42c4-b4a4-7976fe49a393. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextThis priority was stated in prior periods but is not explicitly mentioned in the current disclosures. Revenue showed growth from $6.5 million in 2026-Q1 to $8.3 million in 2026-Q2, which could reflect progress, but no direct current statements confirm ongoing emphasis. Delivery assessment Oct 24, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Sep 25–Oct 24 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 12, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a high-risk, loss-making growth and execution story, not a proven durable compounder. The thesis is in a watch state, and the recent signal shifted from mixed to cautious.
OPTX carries a 2.6-times premium versus peers, based on a valuation model with low confidence. That suggests the market is allowing for a durable premium, but the evidence snapshot does not show how much future growth investors assume; the premium is difficult to assess while the company remains loss-making.
Near-term results show revenue rising from $6.5 million in 2026-Q1 to $8.3 million in 2026-Q2, while operating income moved from a loss to a small profit. This is progress, but recent performance remains below the industry cohort, and management's current disclosures do not directly confirm continued emphasis on partnerships or improving operating income.
Over the next one to three years, the thesis hinges on whether revenue growth and the operating-income improvement continue, and whether proceeds from the public offering support productive acquisitions, investments, and operations. Near-term, rate changes and earnings signals from APH, GLW, and KEYS could affect the Tech sector backdrop; the snapshot gives no direct evidence that these signals will change OPTX's own execution.
The 1-to-3-year view is cautious: operating results have improved, but the company is still loss-making overall, risk is high, and its peer premium rests on a low-confidence valuation model. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.